/ /

Judith M. Orvos, ELS
Judith M. Orvos, ELS, is an editorial consultant for Contemporary OB/GYN.
SNRI may be as effective as estrogen for hot flashes
A small study led by investigators from Brigham and Women’s Hospital suggests that the serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine hydrochloride may be as effective as low-dose estradiol for relief of hot flashes.
Black women at higher risk of triple-negative breast cancer
A new analysis of data from a nationwide hospital-based dataset shows that black women have higher odds of being diagnosed with triple-negative breast cancer—a subtype associated with poorer prognosis—than do white women, regardless of socioeconomic status (SES). The report was published in the June issue of Breast Cancer Research and Treatment.
Moms in second trimester at serious risk of auto accident
A new population-based study by Canadian researchers shows that women in the second trimester of pregnancy run a substantial risk of serious motor vehicle crash. The findings were published in the May 12 edition of The Canadian Medical Association Journal.
Obstructive sleep apnea linked to maternal deaths
A study of a nationally representative sample of hospitalized women who were pregnant or gave birth shows a link between obstructive sleep apnea and maternal death. The findings, published in SLEEP, point to a need for targeted interventions to improve pregnancy outcomes in women with apnea.
FRAX score underestimates fracture recurrence
The World Health Organization’s (WHO) Fracture Risk Assessment tool (FRAX) severely underestimates risk of fragility fracture (FF) in certain patients, according to a new study. Published in the Journal of Clinical Endocrinology & Metabolism, the findings are by Canadian investigators.
Risk of pregnancy complications increased in certain immigrant groups
In certain industrialized nations, immigrant women from sub-Saharan Africa, Latina America, and the Caribbean may be at increased risk of preeclampsia and eclampsia.
SERM plus HT shows promise for perimenopausal symptoms
A small study presented at the 2014 ACOG Annual Clinical Meeting suggests that a selective estrogen receptor modulator (SERM) plus estrogen may have promise in treatment of perimenopausal symptoms. According to Japanese researchers, the combination—known as tissue-selective estrogen complex—improved climacteric symptoms and bone resorption markers without severe side effects.
Smartphone apps useful as OC reminders
A systematic review of Smartphone reminder applications (apps) by investigators at the Ohio State University shows that they may be useful as back-up reminders for patients on oral contraceptives (OCs). The research was presented at the 2014 ACOG Annual Clinical Meeting.
Same-day IUD placement OK for women at high risk of STI
Concerns about asymptomatic sexually transmitted infection (STI) in women at high risk should not delay placement of an intrauterine device (IUD) in women who also are at risk of undesired pregnancy, according to a study by investigators from the University of Pittsburgh. The results, in 366 patients from an inner-city clinic, were presented at the 2014 ACOG Annual Clinical Meeting.
Is Autism in Boys Linked to Prenatal SSRIs?
A population-based study suggests that there may be a link between autism spectrum disorder (ASD) in boys and prenatal exposure to selective serotonin reuptake inhibitors (SSRIs). The researchers caution, however, that interpretation of their findings is complicated by potential recall bias and residual confounding and that maternal depression alone is risky for a fetus.